Understanding Blood Tests

What a blood test can do

A result arriving on your phone can raise more questions than it answers. A name, a number and a flag may tell you that something has been measured, but they cannot tell you why the test was requested or what matters most in your situation. This book gives you a way to read the report and prepare a useful conversation.

A blood test measures something in a sample collected at a particular time. Clinicians use different tests to investigate symptoms, check health, assess risk or monitor a known condition or treatment. A full blood count, for example, measures blood cells; it does not measure every substance or detect every illness. The test chosen depends on the question being asked.

In England, results added to your GP record may be available in the NHS App or NHS account. Hospital results that have not been sent to the GP will not necessarily appear there. You can ask the surgery or relevant hospital team for a copy and an explanation. Seeing a result before an appointment does not mean you have to interpret it alone.

Begin with the question

Write down why the sample was taken, the collection date, the test name, the result, the unit, the laboratory range and any comment. If several tests were ordered, check whether they were a panel or individual measurements. A result can be technically accurate and still need another piece of evidence before its meaning is clear.

The report is one part of an assessment. Symptoms, examination, personal and family history, medicines, previous results and sometimes other tests all change how useful a number is. Results within range do not settle every possible cause of persistent symptoms. Equally, an out-of-range result does not by itself establish a diagnosis. Ask what the team has ruled in, what remains uncertain and what happens next.

Reference intervals and decision limits

A laboratory reference interval describes results observed in a defined reference group, often using the central 95% of that group. For such an interval, some healthy people will fall outside it. A flag means the result is outside the laboratory comparison range; it does not measure the seriousness of a condition. How far a result is from the interval, the test involved and the clinical context all matter.

Ranges can differ by laboratory method and may depend on age, sex or other characteristics. Use the interval printed beside your result, rather than copying numbers from another laboratory or a website. The Gloucestershire NHS table, for example, lists different haemoglobin intervals for adult male and female reference groups. Your clinician can explain which interval is appropriate in your circumstances.

A result near the edge of an interval is not necessarily biologically different from one just across it. The line helps organise a review; it does not divide everyone into two groups with perfectly separate health outcomes. Equally, results in the interval can be relevant when they change substantially from an earlier measurement or do not fit the clinical picture.

A decision limit is designed for a particular decision, such as whether further assessment is needed, rather than simply describing the central values in a reference group. The underlying evidence, purpose and population matter. Ask the clinician which comparison is being used for your result and why. The accompanying review discusses these distinctions for laboratory testing generally; its examples also include fertility testing.

A reference interval is different from a clinical decision limit or an individual treatment target. HbA1c is one example where a result may be considered against diagnostic criteria as well as individual circumstances. Do not assume that the edge of a laboratory interval is a universal diagnostic boundary or an ideal personal target.

Units, flags and trends

The unit is part of the result. A value expressed in grams per litre is not automatically comparable with the same-looking number in a different unit. Decimal points matter. Record the exact name and unit rather than copying the number alone. Ask your practice for an explanation if your report says high, low, abnormal, borderline or no action, especially if the reason is unclear.

Previous results may help distinguish a longstanding pattern from a recent change. But compare like with like: the test, unit, laboratory method, date, clinical situation and any change in medicines can all matter. A small change may reflect ordinary biological or measurement variation; a trend is not meaningful simply because the number moved. The team can say whether repeat testing is useful and when.

Illustration, not a real patient result: imagine a report marks a result just above its own reference interval after a recent illness. That flag is a prompt to ask what was measured, whether the illness or timing may matter, whether the result needs follow-up and when. It is not enough information to decide that the person has a particular disease.

Red cells and oxygen transport

The full blood count, often shortened to FBC, reports measures of red blood cells, white blood cells and platelets. Red cells carry oxygen using haemoglobin. Haemoglobin concentration, the number of red cells and haematocrit, the proportion of blood made up of red cells, give different views of the same broad system.

Low haemoglobin can indicate anaemia, but anaemia describes a finding rather than its cause. Iron deficiency is one possible cause; blood loss, vitamin deficiencies, inflammation and other conditions can also be relevant. A clinician may look at the entire FBC and decide whether iron studies, B12, folate or other investigations fit the question.

Mean cell volume, or MCV, describes average red cell size. Small or large average cells can help narrow possibilities, but either pattern has several potential explanations. A normal average can also conceal variation between individual cells. MCV is a clue to interpret alongside haemoglobin, other indices and the person’s history, not a diagnosis on its own.

White cells and platelets

White blood cells form part of immune defence. The total count groups several cell types; a differential may report neutrophils, lymphocytes and others separately. Counts can change with infections, inflammation, medicines and other circumstances. A clinician considers which type has changed, how much, previous counts and the rest of the clinical picture.

Platelets are cell fragments that help form clots. The platelet count tells you how many are present, not whether they function normally. A low or high count has several possible explanations, and the action can depend on the degree of change, symptoms, medicines and previous values. Ask which part of the FBC needs attention rather than assuming all lines carry the same significance.

Useful questions include: Which cell type is outside its interval? Is the change new? Could the sample or recent illness matter? Is a repeat or a blood film needed? What should I do if my symptoms change while waiting? Your clinician can help decide which questions fit your actual report.

Iron storage and transport

Iron is needed to make haemoglobin. Ferritin is a protein involved in storing iron, and the blood ferritin test helps assess iron stores. Depleted stores can precede a fall in haemoglobin, so an FBC and ferritin answer related but different questions. A normal haemoglobin does not on its own describe the whole picture of iron storage.

Serum iron measures iron circulating in the blood at the time of sampling and varies during the day and between days. It is less useful alone for assessing iron status. Depending on the question, a clinician may consider ferritin with transferrin or total iron binding capacity and transferrin saturation, a calculated measure of how much transport capacity is occupied.

Ferritin can also rise with inflammation, infection or liver disease, as well as with iron overload. A raised ferritin does not automatically prove excess iron; a result within a laboratory interval may need context when inflammation is present. If deficiency is identified, the cause matters too: clinicians may ask about bleeding, absorption, diet or other circumstances rather than treating the number as the entire answer.

Vitamin B12 and folate

Vitamin B12 and folate are involved in making red blood cells. Their deficiency can be associated with a raised average red cell size, but the FBC pattern is not a complete test of either vitamin. B12 deficiency can also affect the nervous system. The choice and interpretation of tests depend on symptoms, history, recent supplementation and the laboratory method.

If your clinician suggests testing, ask what each test is intended to answer and whether recent supplements or treatment could affect the result. If a result is unexpected, ask whether any further assessment is appropriate. Avoid starting, stopping or changing prescribed treatment solely on the basis of an isolated result; agree the next step with the person responsible for your care.

What CRP can and cannot locate

C-reactive protein, or CRP, is made by the liver and can rise in response to inflammation or tissue injury. Clinicians may use it when assessing an illness or monitoring a known inflammatory condition. A raised result supplies evidence that an inflammatory response may be present; it does not identify its cause or location.

A clinician may consider the timing of the sample, symptoms, examination and other results. In some situations a repeat result helps show whether a response is changing. CRP is not a universal test for every inflammatory condition, and a result within the reference interval does not prove that no relevant disease is present. Ask what this particular CRP was intended to help assess.

Erythrocyte sedimentation rate, or ESR, is another marker that can be used in some circumstances. It measures something different and may change at a different pace. An isolated disagreement between markers deserves interpretation, not a conclusion that one must be wrong. Not every person needs both tests.

Creatinine and estimated filtration

Kidneys filter blood and help regulate fluid and salts. A renal panel often includes creatinine and electrolytes. Creatinine is a substance measured in blood; laboratories use it in an equation to estimate the glomerular filtration rate, reported as eGFR. The estimate is useful, but it is not a direct measurement of filtration.

NICE notes that creatinine-based eGFR may be less reliable in situations including acute kidney injury, pregnancy and extremes of muscle mass. An estimate needs interpretation in context. A single unexpected result is not enough on its own to establish chronic kidney disease: clinicians consider the pattern over time and other evidence, and may arrange repeat testing when appropriate.

A helpful discussion separates a current finding from a persistent one. Ask whether an earlier creatinine or eGFR is available, whether the sample was taken during an acute illness, and what follow-up is planned. An estimate reported on one date cannot tell you by itself whether a change is longstanding or whether it will remain the same.

Urine albumin-to-creatinine ratio, or ACR, measures albumin relative to creatinine in urine. It gives different information from blood creatinine and is part of kidney assessment in appropriate circumstances. A blood test labelled kidney function is not the same as a urine ACR, and whether either test is needed depends on the clinical question.

Sodium, potassium and the sample

Sodium and potassium are electrolytes involved in important body functions. A result can be affected by illness, fluid balance, medicines or the sample itself. The significance depends on the degree and direction of change and the person’s condition. Some results require prompt review; others call for a repeat or further assessment. Do not decide urgency from the flag alone.

If you are told a result needs urgent action, follow that advice promptly. For an unclear result, ask who will review it and when. Before a future sample, follow the instructions from the requesting team, including any specific preparation for kidney testing. Never stop a prescribed medicine without their advice.

A panel with different jobs

Liver blood tests are a group of measurements, not a single picture of every liver function. Alanine aminotransferase, or ALT, is an enzyme used as a marker of liver cell injury. Alkaline phosphatase, or ALP, can arise from the liver and other tissues, including bone. Bilirubin and albumin are other measurements that may appear in the panel.

A raised ALT does not identify one cause. ALP may need to be interpreted alongside other results, including GGT where requested, and the clinical history. Albumin and bilirubin also have several influences. The relative pattern, degree and persistence of changes help guide the next question, but one value alone does not tell the whole story.

Your clinician may consider medicines, supplements, alcohol, previous tests, symptoms and additional investigations. Ask which result is being monitored, what the pattern suggests, whether a repeat is needed and what might alter the interpretation. Do not assume an abnormal panel means irreversible damage, or that an in-range panel answers every liver-related question.

A feedback system

The pituitary gland releases thyroid-stimulating hormone, or TSH, which signals the thyroid. Free thyroxine, or FT4, is a measure of thyroid hormone available in the blood. Their relationship helps clinicians assess the feedback system, although the clinical situation affects which tests are useful.

For many adults when pituitary disease is not suspected, NICE recommends considering TSH first, with further thyroid hormone measurements on the same sample if TSH is outside the reference range. Other situations, including suspected pituitary problems or testing children, call for a different initial approach. A single symptom alone does not establish thyroid disease.

Acute illness can affect thyroid tests. NICE also advises asking about biotin supplements because they may interfere with test results. Tell the requesting clinician about medicines and supplements and ask how to prepare; do not independently stop prescribed treatment. If symptoms continue despite an in-range result, discuss what the test has addressed and what else may need consideration.

A snapshot and a longer view

A blood glucose result reflects glucose at the time of sampling. HbA1c measures glycated haemoglobin and provides an estimate of average blood glucose over roughly the preceding two to three months. These tests answer related but different questions. The circumstances of sampling and the reason for testing affect interpretation.

Because HbA1c depends on haemoglobin in red cells, factors that change red cell lifespan or interfere with the laboratory method can affect the reading. A clinical review describes how some anaemias and haemoglobin variants may produce misleading results, although the effect depends on the condition and method. If a glucose reading and HbA1c appear inconsistent, a clinician can investigate the discrepancy and decide which measurements are appropriate.

HbA1c is used for monitoring diabetes and can help diagnose type 2 diabetes in appropriate circumstances. It is not suitable for every diagnostic situation. Pregnancy, suspected type 1 diabetes, recent transfusion, some anaemias and certain haemoglobin variants can change which test is appropriate or how the result is interpreted. Ask whether your result needs confirmation or an alternative test rather than applying a threshold in isolation.

Understanding a lipid profile

A lipid profile may include total cholesterol, LDL cholesterol, HDL cholesterol and triglycerides. Cholesterol travels in the blood in particles called lipoproteins. Total cholesterol combines several components; LDL and HDL describe cholesterol carried in different types of particle. These measurements contribute to cardiovascular risk assessment rather than giving a complete account of risk on their own.

The clinician may consider blood pressure, age, smoking, diabetes and family history alongside the lipid results. The level or target relevant to an individual depends on their circumstances and reason for testing. Ask whether the sample needed fasting, which measure matters for you and how the result fits the wider risk assessment. Do not compare targets intended for different people as though they were a single reference range.

Before the appointment

Preparation is test-specific. Your GP, nurse or specialist should tell you if fasting or another preparation is needed. If the instructions are unclear, contact the requesting team before the appointment rather than guessing. Some tests need no special preparation, while others have requirements related to the question being investigated.

Make a list of prescribed medicines, over-the-counter products and supplements, including biotin. Note recent illness, relevant treatment or other circumstances that the team asks about. The team can advise whether these affect the test or its interpretation. Do not discontinue medication on your own to prepare for a blood test.

Before you leave, make sure the sample request matches the tests your team discussed. If you were unable to follow the preparation instructions, tell the person collecting the sample rather than hiding it; the requesting team can decide whether this matters. Keep a note of the date and where the sample was taken so you can identify the right report later.

If needles are difficult for you, tell the person taking the sample. The NHS suggests letting the healthcare professional know and bringing someone for support if helpful. After the test, ask when and how results will be communicated, who is responsible for discussing them, and how to follow up if you do not hear back.

If the result is unexpected

An unexpected finding may lead to checking the sample, repeating a test, requesting a related test or reviewing the clinical history. A repeat does not necessarily mean the first result was wrong; it may answer whether a change persists. The timing and urgency are decisions for the care team, not a fixed rule that applies to every marker.

If a result is marked abnormal and you have not received an explanation, contact the requesting team or your GP practice. If the report contains a clear instruction to seek prompt review, act on that instruction rather than waiting for a routine discussion. If you feel seriously unwell, seek appropriate urgent help independently of a test result.

Bring the report and the story

Before your appointment, choose the two or three concerns that matter most to you. Describe when symptoms began, whether they are changing, their effect on daily life and any pattern you have noticed. Bring the actual report, not just a screenshot of a single flag, as well as relevant older results and your medicines and supplements list.

Ask: What was this test intended to investigate? Which results matter in my case, and why? What are their units and the laboratory’s reference intervals? Does a previous result change the interpretation? Could illness, medicines or supplements affect it? What can this test exclude, and what can it not exclude?

Then agree a plan: Do I need a repeat or another investigation? When will it happen and who will arrange it? What would change the plan? When should I contact you sooner? If the results do not explain the symptoms, what is the next step? Write down the answer, the person responsible and the expected date so that you can follow up.

When the answer is still uncertain

A test result is information, not a verdict on whether your experience is real. Sometimes the initial tests do not identify an explanation. That can be frustrating, especially when symptoms are affecting work, sleep or everyday life. A useful consultation can still establish what has been considered, what remains open and how you will be reviewed.

Ask for an explanation in plain language and for a copy of the plan if that helps. You can ask which changes should trigger another appointment, whether a specialist opinion is appropriate and how to report a worsening symptom. This book supports those conversations; it cannot interpret your personal results or replace clinical assessment.